Willow Biosciences (CANSF) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc. is a Canadian biotechnology company that develops and manufactures specialty cannabinoids through fermentation-based production. Leveraging a proprietary yeast platform, the company engineers strains to produce high‐purity rare cannabinoids such as cannabigerol (CBG), cannabidiol (CBD) and other minor cannabinoids. This approach offers a scalable, consistent and sustainable alternative to traditional plant extraction methods, addressing supply chain challenges and quality variability associated with botanical sources.

The company operates a demonstration‐scale biomanufacturing facility in Calgary, Alberta, where it optimizes fermentation processes, downstream extraction and purification protocols. Willow Biosciences collaborates with contract development and manufacturing organizations (CDMOs) and academic partners to advance process development and analytical capabilities. Its products target pharmaceutical, nutraceutical, cosmetic and research markets, supplying active pharmaceutical ingredient (API)‐grade cannabinoids for drug development, clinical trials and consumer product formulations.

Founded in 2015 by alumni of the University of Calgary’s Synthetic Biology Centre, Willow Biosciences went public on the Canadian Securities Exchange under the ticker “WBIO” and trades in the U.S. over‐the‐counter market as CANSF. The company is led by President and Chief Executive Officer Kam Daya, whose team brings expertise in bioprocess engineering, regulatory affairs and life‐science commercialization. Willow Biosciences continues to expand its product pipeline and scale its manufacturing capacity to meet growing global demand for high‐purity cannabinoid ingredients.

Key Stats

• Today's Range: $0.11 to $0.11
• 50-Day Range: $0.11 to $0.14
• 52-Week Range: $0.07 to $0.25
• Volume: 160 shs
• Average Volume: 5,948 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 6/11/2026
• Next Earnings (Estimated): 8/17/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CANSF
• CIK: N/A
• Web: www.willowbio.com
• Phone: (403) 910-5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A